HER2 and EGFR amplification and expression in urothelial carcinoma occurs in distinct biological and molecular contexts

We analyzed a cohort of 599 cases of urothelial carcinoma for EGFR, ERBB2, and ERBB3 gene expression and genomic alterations. The cohort consisted of a reference set (n = 292) comprising all stages and grades and one set (n = 307) of advanced tumors. All cases were previously classified into urothel...

Descripción completa

Detalles Bibliográficos
Autores principales: Eriksson, Pontus, Sjödahl, Gottfrid, Chebil, Gunilla, Liedberg, Fredrik, Höglund, Mattias
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5564734/
https://www.ncbi.nlm.nih.gov/pubmed/28388586
http://dx.doi.org/10.18632/oncotarget.16554

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5564734/
https://www.ncbi.nlm.nih.gov/pubmed/28388586
http://dx.doi.org/10.18632/oncotarget.16554

Ejemplares similares